Table 1 Baseline characteristics
Variables | Total (n = 1154) | CA-AKIA | CA-AKIB | ||||
|---|---|---|---|---|---|---|---|
|  |  | Yes (n = 98) | No (n = 1056) | p value | Yes (n = 149) | No (n = 1005) | p value |
Age, y | 64.46 ± 10.55 | 70.24 ± 9.45 | 63.92 ± 10.49 |  < 0.001 | 66.42 ± 11.41 | 64.17 ± 10.39 | 0.024 |
Age ≥ 75, n (%) | 213 (18.5) | 37 (37.8) | 176 (16.7) | < 0.001 | 41 (27.5) | 172 (17.1) | 0.003 |
Female sex, n (%) | 320 (27.73) | 34 (34.69) | 286 (27.08) | 0.107 | 49 (32.89) | 271 (26.97) | 0.132 |
Weight, kg | 66.48 ± 10.68 | 64.3 ± 11.42 | 66.68 ± 10.59 | 0.050 | 65.60 ± 11.45 | 66.61 ± 10.56 | 0.312 |
SBP, mmHg | 131.12 ± 20.80 | 131.42 ± 27.21 | 131.09 ± 20.12 | 0.906 | 129.00 ± 24.58 | 131.43 ± 20.17 | 0.251 |
DBP, mmHg | 76.65 ± 12.06 | 77.10 ± 13.99 | 76.61 ± 11.87 | 0.738 | 76.64 ± 13.41 | 76.65 ± 11.85 | 0.988 |
HR, bpm | 76.39 ± 13.99 | 81.13 ± 17.17 | 75.95 ± 13.59 | 0.005 | 79.01 ± 16.14 | 76.00 ± 13.61 | 0.032 |
CHF, n (%) | 733 (63.52) | 79 (80.61) | 654 (61.93) | < 0.001 | 106 (71.14) | 627 (62.39) | 0.042 |
CAD, n (%) | 1074 (93.07) | 96 (97.96) | 978 (92.61) | 0.054 | 139 (93.29) | 935 (93.03) | 0.991 |
Hypotension, n (%) | 22 (1.91) | 9 (9.18) | 13 (1.23) | < 0.001 | 11 (7.38) | 11 (1.09) | < 0.001 |
LVEF, % | 56.97 ± 13.05 | 50.54 ± 13.57 | 57.59 ± 12.84 | < 0.001 | 53.15 ± 13.72 | 57.56 ± 12.85 | < 0.001 |
LVEF < 40%, n (%) | 119 (10.31) | 18 (18.37) | 101 (9.56) | 0.011 | 23 (15.44) | 96 (9.55) | 0.046 |
Hypertension, n (%) | 777 (67.33) | 75 (76.53) | 702 (66.48) | 0.044 | 103 (69.13) | 674 (67.06) | 0.628 |
Anemia, n (%) | 407 (35.27) | 49 (50.00) | 358 (33.90) | 0.001 | 56 (37.58) | 351 (34.93) | 0.561 |
AMI, n (%) | 379 (32.84) | 56 (57.14) | 323 (30.59) | < 0.001 | 76 (51.01) | 303 (30.15) | < 0.001 |
eGFR < 60 ml/min/1.73 m2, n (%) | 268 (23.2) | 33 (33.7) | 235 (22.3) | 0.016 | 41 (27.5) | 227 (22.6) | 0.230 |
LDL-C, mmol/L | 2.67 ± 0.96 | 2.99 ± 1.05 | 2.65 ± 0.95 | 0.009 | 2.97 ± 1.28 | 2.63 ± 0.90 | 0.007 |
HDL-C, mmol/L | 1.01 ± 2.20 | 0.94 ± 0.24 | 1.02 ± 2.28 | 0.340 | 0.95 ± 0.26 | 1.02 ± 2.35 | 0.365 |
HS-CRP, mg/L | 19.02 ± 37.45 | 38.72 ± 51.47 | 17.04 ± 35.18 | < 0.001 | 31.99 ± 46.06 | 16.91 ± 35.45 | < 0.001 |
SCR, μmol/L | 96.09 ± 47.36 | 126.4 ± 62.6 | 93.28 ± 44.69 | < 0.001 | 96.07 ± 54.58 | 96.10 ± 46.22 | 0.996 |
Hemoglobin, g/L | 131.03 ± 16.30 | 122.34 ± 20.22 | 131.74 ± 15.73 | < 0.001 | 130.11 ± 18.34 | 131.15 ± 16.01 | 0.552 |
HbA1c, % | 7.60 ± 1.53 | 7.79 ± 1.60 | 7.58 ± 1.52 | 0.250 | 130.11 ± 18.34 | 131.15 ± 16.01 | 0.830 |
Serum albumin, g/L | 35.09 ± 4.59 | 31.81 ± 5.27 | 35.35 ± 4.43 | < 0.001 | 33.90 ± 5.58 | 35.25 ± 4.43 | 0.013 |
ACEI/ARB, n (%) | 1028 (89.08) | 81 (82.65) | 947 (89.68) | 0.033 | 131 (87.92) | 897 (89.25) | 0.626 |
Beta-blocker, n (%) | 979 (84.84) | 71 (72.45) | 908 (85.98) | < 0.001 | 120 (80.54) | 859 (85.47) | 0.110 |
Statin, n (%) | 1126 (97.57) | 94 (95.92) | 1032 (97.73) | 0.290 | 145 (97.32) | 981 (97.61) | 0.776 |
Diuretics, n (%) | 261 (22.62) | 49 (50.00) | 212 (20.08) | < 0.001 | 57 (38.26) | 204 (20.30) | < 0.001 |
Metformin, n (%) | 79 (6.85) | 2 (2.04) | 77 (7.29) | 0.085 | 7 (4.70) | 72 (7.16) | 0.422 |
PCI, n (%) | 710 (61.53) | 58 (59.18) | 652 (61.74) | 0.160 | 89 (59.73) | 621 (61.79) | 0.174 |
CV, mL | 131.55 ± 63.85 | 137.09 ± 63.05 | 131.04 ± 63.93 | 0.366 | 130.27 ± 63.2 | 131.74 ± 63.98 | 0.791 |
Periprocedure IABP, n (%) | 59 (5.11) | 25 (25.51) | 34 (3.22) | < 0.001 | 23 (15.44) | 36 (3.58) | < 0.001 |
Mehran score | 6.37 ± 4.53 | 11.08 ± 6.35 | 5.92 ± 4.04 |  < 0.001 | 8.36 ± 6.09 | 6.07 ± 4.17 | < 0.001 |